Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study.
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes.
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment.
Targeting Innate Inflammation Pathways to Treat Ocular Infections
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting Innate Inflammation Pathways to Treat Ocular Infections
Biography
contributor
Principal Investigator
Overview
sponsor award id
R21EY035725
Time
start date
2024-01-01
end date
2025-12-31